Humoral immunity after Pfizer/BioNTech BNT162b2 vaccine in healthcare workers of ASL Roma 2 (Italy)
2021; PAGEPress (Italy); Volume: 36; Issue: 2 Linguagem: Inglês
10.4081/mm.2021.9695
ISSN2280-6423
AutoresEliana Giberna, Tiziana Guastafierro, Natalia Ciaffi, E. Nebuloso, S Piccoli, Mattia Serao, Giuseppina Gioffrè, Stefania Campitelli, Maria Grazia Colace, Maria Carmela Cava, Maria De Cristofaro,
Tópico(s)Bacterial Infections and Vaccines
ResumoThe Unit (COU) of Microbiology and Virology of Sandro Pertini Hospital began monitoring the immune response on a cohort of healthcare operators who received the Pfizer/BioNTech BNT162b2 vaccine. Three different tests for the detection of antibodies against SARS-CoV-2 were used showing 100% of seroconversion after 28 days from the first dose.
Referência(s)